[A double-blind dose ranging study of weekly subcutaneous administration of rHuEPO (KRN5702) on post-phlebotomy anemia of patients scheduled for predeposit autologous blood transfusion (multicenter late PhII study)].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples